$0.2650
At close: May 3, 1:57 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Oncopeptides in recent months.
Browse guidance and forecast on all stocks.